Mustang Historical Income Statement
| MBIO Stock | USD 0.22 0.01 4.76% |
Historical analysis of Mustang Bio income statement accounts such as Research Development of 36.8 M can show how well Mustang Bio performed in making a profits. Evaluating Mustang Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Mustang Bio's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Mustang Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mustang Bio is a good buy for the upcoming year.
Mustang |
About Mustang Income Statement Analysis
Mustang Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Mustang Bio shareholders. The income statement also shows Mustang investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Mustang Bio Income Statement Chart
Add Fundamental
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Mustang Bio. It is also known as Mustang Bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Mustang Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Mustang Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.At this time, Mustang Bio's Interest Expense is very stable compared to the past year. As of the 18th of October 2024, Depreciation And Amortization is likely to grow to about 2.3 M, while Selling General Administrative is likely to drop about 9 M.
Mustang Bio income statement Correlations
Click cells to compare fundamentals
Mustang Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Mustang Bio income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 1.8M | 3.9M | 15K | 3.4M | 1.3M | 1.4M | |
| Selling General Administrative | 9.6M | 9.5M | 11.0M | 12.2M | 9.7M | 9.0M | |
| Gross Profit | (1.4M) | (1.8M) | (2.3M) | (3.0M) | (2.2M) | (2.1M) | |
| Operating Income | (45.9M) | (56.8M) | (66.7M) | (76.2M) | (50.7M) | (53.3M) | |
| Net Income From Continuing Ops | (46.4M) | (60.0M) | (66.4M) | (77.5M) | (62.6M) | (65.8M) | |
| Ebit | (45.9M) | (57.9M) | (68.7M) | (77.2M) | (50.7M) | (53.3M) | |
| Research Development | 36.3M | 47.3M | 55.7M | 63.9M | 39.2M | 36.8M | |
| Cost Of Revenue | 1.4M | 1.8M | 2.3M | 3.0M | 2.2M | 1.3M | |
| Total Operating Expenses | 45.9M | 56.8M | 66.7M | 74.9M | 48.5M | 45.5M | |
| Income Before Tax | (46.4M) | (60.0M) | (66.4M) | (77.5M) | (51.6M) | (54.2M) | |
| Total Other Income Expense Net | (504K) | (3.2M) | 353K | (1.4M) | (876K) | (832.2K) | |
| Net Income Applicable To Common Shares | (46.4M) | (60.0M) | (66.4M) | (77.5M) | (69.8M) | (66.3M) | |
| Net Income | (48.2M) | (62.1M) | (64.1M) | (78.9M) | (51.6M) | (54.2M) | |
| Income Tax Expense | 1.8M | 2.1M | (2.3M) | 1.4M | 1.2M | 1.2M | |
| Net Interest Income | (504K) | (3.2M) | 353K | (2.7M) | (4.2M) | (4.0M) | |
| Interest Income | 1.3M | 708K | 368K | 689K | 1.1M | 710.6K | |
| Depreciation And Amortization | 2.6M | 1.8M | 2.3M | 3.0M | 2.2M | 2.3M | |
| Other Operating Expenses | 45.9M | 56.8M | 66.7M | 74.9M | 50.7M | 50.8M | |
| Ebitda | (43.3M) | (56.1M) | (66.4M) | (74.2M) | (48.5M) | (50.9M) | |
| Non Recurring | 12.4M | 3.4M | 6.3M | 10.1M | 11.6M | 8.4M | |
| Non Operating Income Net Other | 505K | 569K | 1.3M | 708K | 814.2K | 638.4K | |
| Reconciled Depreciation | 1.4M | 1.8M | 2.3M | 3.0M | 2.7M | 1.9M |
Pair Trading with Mustang Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mustang Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Mustang Stock
Moving against Mustang Stock
| 0.88 | GILD | Gilead Sciences | PairCorr |
| 0.72 | FLGC | Flora Growth Corp | PairCorr |
| 0.71 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.65 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.45 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
The ability to find closely correlated positions to Mustang Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mustang Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mustang Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mustang Bio to buy it.
The correlation of Mustang Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mustang Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mustang Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mustang Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.72) | Revenue Per Share (0) | Return On Assets (1.05) | Return On Equity (11.91) |
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.